Seroprevalence of hepatitis E in adults in Brazil: a systematic review and meta-analysis

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP TENGAN, Fatima Mitiko FMUSP-HC
PRATA, Thamiris V. G. FMUSP-HC
BERNARDO, Wanderley M. FMUSP-HC 2019
dc.identifier.citation INFECTIOUS DISEASES OF POVERTY, v.8, article ID 3, 10p, 2019
dc.identifier.issn 2095-5162
dc.description.abstract BackgroundHepatitis E virus (HEV) is a member of the Hepeviridae family; it has four main genotypes and one serotype. While genotypes 1 and 2 cause epidemic hepatitis and are transmitted via water and the fecal-oral route, genotypes 3 and 4 are zoonotic. In the various seroprevalence studies of hepatitis E in Brazil, the numbers reported vary widely and are difficult to interpret. The aim of this study was to analyze existing seroprevalence studies of hepatitis E in adults in Brazil.Main textWe searched the PubMed, Latin American and Caribbean Health Sciences and Embase databases for studies published from inception to May 12, 2018 concerning infection by HEV in Brazil without time period or language restrictions. We included studies that presented data concerning hepatitis E seroprevalence in adults in Brazil, had a sample size 50 patients and whose method used for the detection of anti-HEV was standardized and commercialized. We also evaluated the quality of the articles using a list of criteria that totalized 9 items. Of the 20 studies ultimately analyzed, 10 (50%) were from the southeast region of Brazil, 3 (15%) were from the central-west region, 3 (15%) were from the northern region, 2 (10%) were from the northeast region and 2 (10%) were from the southern region. Regarding the quality evaluation of the studies, the mean score was 5.6 (range: 4-8). The estimated overall seroprevalence of HEV infection in the adult population was 6.0% (95% CI: 5.0-7.0); in subgroup analyses, we observed that the prevalence of anti-HEV antibodies in blood donors was 7.0% (95% CI: 5.0-8.0), whereas in the general population, it was 3.0% (95% CI: 2.0-4.0).ConclusionsThe results of this systematic review indicate that there should be national investment in the prevention of hepatitis E virus infection in Brazil, including the implementation of improvements in basic sanitation and guidance regarding the appropriate handling of animal waste and the optimal cooking of vegetables, meat and their derivatives.
dc.language.iso eng
dc.publisher BMC
dc.relation.ispartof Infectious Diseases of Poverty
dc.rights openAccess
dc.subject Hepatitis E; Hepatitis E virus; Brazil; Prevalence; Systematic review
dc.subject.other e virus-infection; local grocery stores; pig livers sold; blood-donors; transplant recipients; high prevalence; risk-factors; 1st report; genotype 4; antibodies
dc.title Seroprevalence of hepatitis E in adults in Brazil: a systematic review and meta-analysis
dc.type article
dc.rights.holder Copyright BMC LIM/47 LIM/52
dc.identifier.doi 10.1186/s40249-018-0514-4
dc.identifier.pmid 30646964
dc.type.category review
dc.type.version publishedVersion TENGAN, Fatima Mitiko:FM:MIP FIGUEIREDO, Gerusa M.:IMT:IMT NUNES, Arielle K. S.:FM: MANCHIERO, Carol:HC:ICHC DANTAS, Bianca P.:HC:INCOR MAGRI, Mariana C.:FM: PRATA, Thamiris V. G.:FM: MAZZA, Celso C.:HC:ICHC ABDALA, Edson:FM:MIP BARONE, Antonio A.:FM:MIP BERNARDO, Wanderley M.:FM: · NASCIMENTO, Marisa:Univ Sao Paulo, Sch Med, Clin Hosp, Nursing Div, Sao Paulo, SP, Brazil WOS:000455822000001 2-s2.0-85060032636 LONDON ENGLAND
hcfmusp.relation.reference · Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12
· Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x
· BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
· Bortoliero André Luiz, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P87, DOI 10.1590/S0036-46652006000200006
· Boutrouille A, 2007, J CLIN MICROBIOL, V45, P2009, DOI 10.1128/JCM.00235-07
· Brassard J, 2012, APPL ENVIRON MICROB, V78, P3763, DOI 10.1128/AEM.00251-12
· Bricks G, 2018, BRAZ J INFECT DIS, V22, P85, DOI 10.1016/j.bjid.2018.02.001
· Colson P, 2012, EMERG INFECT DIS, V18, P1361, DOI 10.3201/eid1808.111827
· Crossan C, 2012, EMERG INFECT DIS, V18, P2085, DOI 10.3201/eid1812.120924
· Cruells M R, 1997, Gastroenterol Hepatol, V20, P295
· dos Santos DCM, 2002, MEM I OSWALDO CRUZ, V97, P637, DOI 10.1590/S0074-02762002000500007
· Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
· Feagins AR, 2008, INT J FOOD MICROBIOL, V123, P32, DOI 10.1016/j.ijfoodmicro.2007.11.068
· Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0
· Ferreira AC, 2018, ARCH VIROL, V163, P43, DOI 10.1007/s00705-017-3562-3
· Focaccia R, 1998, BRAZ J INFECT DIS, V2, P269
· Gao SY, 2015, INT J ENV RES PUB HE, V12, P2026, DOI 10.3390/ijerph120202026
· Goncales NSL, 2000, CLIN DIAGN LAB IMMUN, V7, P813, DOI 10.1128/CDLI.7.5.813-816.2000
· Hartl J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080211
· Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427
· Ibarra H, 1997, REV MED CHILE, V125, P275
· Jeblaoui A, 2013, CLIN INFECT DIS, V57, pE122, DOI 10.1093/cid/cit291
· Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150
· Kiesslich D, 2002, T ROY SOC TROP MED H, V96, P215, DOI 10.1016/S0035-9203(02)90311-1
· Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111
· Kokkinos P, 2012, FOOD ENVIRON VIROL, V4, P179, DOI 10.1007/s12560-012-9087-8
· Lewis HC, 2010, EPIDEMIOL INFECT, V138, P145, DOI 10.1017/S0950268809990847
· dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021
· Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371
· Wassaf MGM, 2014, J CLIN VIROL, V61, P334, DOI 10.1016/j.jcv.2014.08.016
· Martins RMB, 2014, J CLIN VIROL, V59, P188, DOI 10.1016/j.jcv.2014.01.002
· Meng XJ, 2013, SEMIN LIVER DIS, V33, P41, DOI 10.1055/s-0033-1338113
· Meng XJ, 1998, J VIROL, V72, P9714
· Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.b2535, 10.1002/14651858.CD008242.pub3, 10.1002/14651858.CD008216.pub4, 10.1371/journal.pmed.1000097, 10.1016/j.jclinepi.2010.02.006, 10.1136/bmj.c869]
· Munn Z, 2015, INT J EVID-BASED HEA, V13, P147, DOI 10.1097/XEB.0000000000000054
· de Oliveira JMNS, 2018, INT J INFECT DIS, V69, P41, DOI 10.1016/j.ijid.2018.01.032
· PANG L, 1995, AM J TROP MED HYG, V52, P347, DOI 10.4269/ajtmh.1995.52.347
· Parana R, 1997, AM J TROP MED HYG, V57, P60, DOI 10.4269/ajtmh.1997.57.60
· Passos AM, 2013, J MED VIROL, V85, P615, DOI 10.1002/jmv.23494
· Passos-Castilho AM, 2017, BRAZ J INFECT DIS, V21, P535, DOI 10.1016/j.bjid.2017.05.004
· Passos-Castilho AM, 2016, BRAZ J INFECT DIS, V20, P262, DOI 10.1016/j.bjid.2016.03.001
· Passos-Castilho AM, 2016, J MED VIROL, V88, P361, DOI 10.1002/jmv.24336
· Song YJ, 2010, J MED VIROL, V82, P583, DOI 10.1002/jmv.21730
· Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1
· Teshale EH, 2015, J INFECT DIS, V211, P366, DOI 10.1093/infdis/jiu466
· Trinta KS, 2001, MEM I OSWALDO CRUZ, V96, P25, DOI 10.1590/S0074-02762001000100004
· Vitral CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-458
· Yu YH, 2009, INFECT GENET EVOL, V9, P554, DOI 10.1016/j.meegid.2009.02.008
dc.description.index MEDLINE
dc.identifier.eissn 2049-9957
hcfmusp.citation.scopus 0
hcfmusp.citation.wos 0 Brasil

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account